Sign in
4/A

Changes in Ownership

Gain Therapeutics, Inc. Filed Acc 0001209191-22-025180

Chief Executive Officer bought 4,922 shares at $7.87 ($38,716)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
RICHMAN ERIC I Chief Executive Officer 2021-08-16 Purchase +4,922 $7.87 $38,716 216,820 D
Open-market purchases · 4,922 sh · avg $7.87 · $38,716
Loading xslF345X03/doc4a.xml…